Back
IBRX
Description
Description
ImmunityBio, Inc. is a clinical stage immunotherapy company. The company is headquartered in San Diego, California and currently employs 673 full-time employees. The company went IPO on 2015-07-28. Using its applied science and platforms to treat cancers, including the development of potential cancer vaccines, as well as developing immunotherapies and cell therapies to reduce or eliminate the need for standard high-dose chemotherapy. Its platforms and their associated product candidates are designed to attack cancer and infectious pathogens by ...
Show more
NYSE/NASDAQ
Performance
Performance
$6.62
USD
▲ $0.14 (2.16%)
13th February 2026, 12:58 a.m.
1M
1Y
10Y
GRAPH
TABLE
GRAPH
TABLE
* US price history does not take into account stock splits
Quick facts
Quick facts
▼ -15.72% Growth
5 year average annual growth
N/A
5 year average dividend yield
$15 AUD minimum investment
Due to minimum AUD to USD conversion
$1,522.49 USD median portfolio
Median amount held by the community
Costs
Costs
PURCHASE FEE
$6.50 AUD (or $5.50 with Pearler Prepay)
MANAGEMENT FEE
N/A
ESG
ESG
39.28
Environmental score
52.63
Social score
35.56
Governance score
Community insights
Community insights
General statistics
7 investors hold IBRX
44 weeks average time between investments
$785 average holding per investor
15 hours since last community investment
Demographics
Income of investors
50k - 100k
33%
150k - 200k
33%
Less than 50k
22%
100k - 150k
11%
More than 200k
0%
Age of investors
35-90 years old
57%
26-34 years old
29%
18-25 years old
14%
Legal gender of investors
29% male
71% female
Related items
Related items
Pricing data reflects the most recent end-of-day traded price. Live pricing is shown at the time of buy/sell and may differ from what's displayed here. Other data is provided by our data partner, last updated on Fri Feb 13 2026, and may have changed since.
Learn more
Learn more
Why are gold and silver prices surging?
READ
Portfolios
Gold and silver are going gangbusters right now. This guide breaks down the factors that influence their prices.
30 January 2026
・
Nick Nicolaides
・
6 min read
0 likes
・
29 views
A simple view of the markets in 2026 (and what I’m doing)
READ
Long Term Investing
A clear, no-hype guide to the most common places to invest your savings, plus what to consider before choosing what fits...
13 January 2026
・
Dave Gow
・
8 min read
13 likes
・
1979 views
Episode 13. Using super to buy a home quicker
LISTEN
In your Financial Independence Retire Early (FIRE) travels, you may have heard of the First Home Super Saver Scheme. To ...
Fri, 24th May 2024
・
46 min
・
1 like
Episode 36. Using leverage in the share market
LISTEN
You may well have heard the (correct) adage that investing carries risk. And if you’ve ever missed a mortgage, credit ca...
Fri, 11th April 2025
・
58 min
・
1 like
Episode 181. What to do with your shares at tax time
LISTEN
It’s tax time – so what happens to your shares, ETFs, and micro-investing apps when you’re doing your return? This episo...
Wed, 23rd July 2025
・
17 min
・
3 likes
Episode 136. Should I sell my shares with everything that's going on in the US right now?
LISTEN
It’s an inescapable truth that the Australian shares market can sway under the influence of the US. Beyond the close tie...
Mon, 17th February 2025
・
15 min
・
0 likes
US stock
ASK & ANSWER
Shares and Crypto
What are the best tech stocks to invest now in the US market?
K-Investor
•
July 27th, 2022
1 like
・
52 views
・
US ETFs vs AU ETFs
ASK & ANSWER
Investing Strategy
Are there any downsides to choosing US ETFs over AU ones? Some of the US ETFs outperform AU ones, but as an Australian c...
Stephanie Conroy
•
April 3rd, 2024
0 likes
・
400 views
・
AU vs US shares
ASK & ANSWER
First Time Investor
Hi, I’m fairly new to investing and this is a dumb question but what is the difference when investing in the AU shares v...
Molly Pearse
•
January 29th, 2023
5 likes
・
208 views
・
Aus v US shares - smart to invest in both?
ASK & ANSWER
Investing Strategy
I currently hold shares in various Australian ETFs including VDHG, NDQ, ETHI, etc. My question is whether I should also ...
Stephanie Varga
•
May 16th, 2023
3 likes
・
37 views
・